Login / Signup

Delays in thrombolysis during COVID-19 are associated with worse neurological outcomes: the Society of Vascular and Interventional Neurology Multicenter Collaboration.

Dinesh V JillellaFadi NahabThanh N NguyenMohamad AbdalkaderDavid S LiebeskindNirav VoraVivek RaiDiogo C HaussenRaul G NogueiraShashvat DesaiAshutosh P JadhavAlexandra L CzapAlicia M ZhaItalo LinfanteAmeer E HassanDarko Quispe-OrozcoSantiago Ortega-GutierrezPriyank KhandelwalPratit PatelOsama ZaidatTudor G JovinScott KamenJames E Siegler
Published in: Journal of neurology (2021)
Treatment delays observed during the COVID-19 pandemic led to greater early mortality and hospice care, with a lower probability of discharge to home/rehabilitation facility. There was no effect modification of treatment delay on admission during the pandemic, indicating that treatment delay at any time contributes similarly to these short-term outcomes.
Keyphrases
  • healthcare
  • palliative care
  • emergency department
  • clinical trial
  • type diabetes
  • coronary artery disease
  • quality improvement
  • risk factors
  • cross sectional
  • brain injury
  • pain management